Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.
2.
3.

C2GnT-M is downregulated in colorectal cancer and its re-expression causes growth inhibition of colon cancer cells.

Huang MC, Chen HY, Huang HC, Huang J, Liang JT, Shen TL, Lin NY, Ho CC, Cho IM, Hsu SM.

Oncogene. 2006 Jun 1;25(23):3267-76. Epub 2006 Jan 16.

PMID:
16418723
4.

Expression of the high-affinity selectin glycan ligand C2-O-sLeX by colon carcinoma cells.

St Hill CA, Bullard KM, Walcheck B.

Cancer Lett. 2005 Jan 10;217(1):105-13.

PMID:
15596301
5.
7.

Structurally distinct requirements for binding of P-selectin glycoprotein ligand-1 and sialyl Lewis x to Anaplasma phagocytophilum and P-selectin.

Yago T, Leppänen A, Carlyon JA, Akkoyunlu M, Karmakar S, Fikrig E, Cummings RD, McEver RP.

J Biol Chem. 2003 Sep 26;278(39):37987-97. Epub 2003 Jul 7.

8.

Model glycosulfopeptides from P-selectin glycoprotein ligand-1 require tyrosine sulfation and a core 2-branched O-glycan to bind to L-selectin.

Leppänen A, Yago T, Otto VI, McEver RP, Cummings RD.

J Biol Chem. 2003 Jul 18;278(29):26391-400. Epub 2003 May 7.

9.

Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data.

Ramakers C, Ruijter JM, Deprez RH, Moorman AF.

Neurosci Lett. 2003 Mar 13;339(1):62-6.

PMID:
12618301
10.

The monoclonal antibody CHO-131 binds to a core 2 O-glycan terminated with sialyl-Lewis x, which is a functional glycan ligand for P-selectin.

Walcheck B, Leppanen A, Cummings RD, Knibbs RN, Stoolman LM, Alexander SR, Mattila PE, McEver RP.

Blood. 2002 Jun 1;99(11):4063-9.

11.
12.

General aspects of anti-angiogenesis and cancer therapy.

Zogakis TG, Libutti SK.

Expert Opin Biol Ther. 2001 Mar;1(2):253-75. Review.

PMID:
11727534
13.
14.

Severe impairment of leukocyte rolling in venules of core 2 glucosaminyltransferase-deficient mice.

Sperandio M, Thatte A, Foy D, Ellies LG, Marth JD, Ley K.

Blood. 2001 Jun 15;97(12):3812-9.

16.

Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis.

Borsig L, Wong R, Feramisco J, Nadeau DR, Varki NM, Varki A.

Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3352-7.

17.

Endothelial and epithelial expression of sialyl Lewis(x) in squamous carcinoma of the tongue.

Renkonen J, Heinävaara S, Sankila R, Paavonen T.

APMIS. 2000 Oct;108(10):705-12.

PMID:
11200826
18.

The relative activities of the C2GnT1 and ST3Gal-I glycosyltransferases determine O-glycan structure and expression of a tumor-associated epitope on MUC1.

Dalziel M, Whitehouse C, McFarlane I, Brockhausen I, Gschmeissner S, Schwientek T, Clausen H, Burchell JM, Taylor-Papadimitriou J.

J Biol Chem. 2001 Apr 6;276(14):11007-15. Epub 2000 Dec 15.

19.

Control of O-glycan branch formation. Molecular cloning and characterization of a novel thymus-associated core 2 beta1, 6-n-acetylglucosaminyltransferase.

Schwientek T, Yeh JC, Levery SB, Keck B, Merkx G, van Kessel AG, Fukuda M, Clausen H.

J Biol Chem. 2000 Apr 14;275(15):11106-13.

20.

Noncovalent association of P-selectin glycoprotein ligand-1 and minimal determinants for binding to P-selectin.

Epperson TK, Patel KD, McEver RP, Cummings RD.

J Biol Chem. 2000 Mar 17;275(11):7839-53.

Supplemental Content

Support Center